OHP-019 Assessment of four manual infusion devices of [18f]-fluorodeoxyglucose in a nuclear medicine department

    loading  Checking for direct PDF access through Ovid



In nuclear medicine, [18F]-fluorodeoxyglucose (18-FDG) is usually administered in unit doses partitioned from multi-dose vials in radiopharmacy. Administration can be performed manually or automatically. In a nuclear medicine department where the dispensing system used is the Unidose by TRASIS, administrations have to be performed manually. The infusion sets selected should reduce radiation exposure to the staff involved, improve administration accuracy and mitigate contamination.


To assess four infusion devices. There is no guideline for the 18-FDG infusion device.

Material and methods

The evaluation focused on five criteria:

Material and methods

The four devices tested were:

Material and methods

(1) a conventional infusion device with a 3 way stopcock (n=10), (2) a device with a 3 way stopcock and 2 non-return valves (n=9), (3) an infusion device marketed by DORAN with a 3 way stopcock and two non-return valves (n=8) and (4) a device marketed by TRASIS without a 3 way stopcock but with 2 non-return valves (n=6).


The price gradually increased between devices (1) and (4) (from €0.4 to €4.97 TTC/device).


The results suggest staff choices as device (3) or (4). Nevertheless, staff training is necessary for optimal use of these devices.


No conflict of interest

Related Topics

    loading  Loading Related Articles